USD 8.23
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 753.05 Million | 1.11 Billion | 300.5 Million | 200.41 Million | 169.48 Million | 240.1 Million |
Net Income | 330.67 Million | 517.1 Million | 30.96 Million | -195.73 Million | -52.31 Million | -17.22 Million |
Depreciation & Amortization | 462.9 Million | 567.31 Million | 278.02 Million | 336.95 Million | 297.55 Million | 110.44 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 393.09 Thousand | 2.39 Million | 713.69 Thousand | 1.03 Million | 4.69 Million | 4.54 Million |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -40.92 Million | 26.65 Million | -9.19 Million | 58.15 Million | -80.45 Million | 322.64 Million |
Investing Cash Flow | -637.23 Million | -1.06 Billion | 82.86 Million | -292.3 Million | -269.35 Million | -266.72 Million |
Investments in PPE | -300.29 Million | -268.54 Million | -111.14 Million | -191.11 Million | -196.66 Million | -245.53 Million |
Acquisitions | -520.33 Million | -842.55 Million | 110.92 Million | 8.91 Million | -178.89 Million | 16.86 Million |
Investment purchases | -35.02 Million | -19.64 Million | -31.54 Million | -100.83 Million | -120.17 Million | -56.81 Million |
Sales/Maturities of investments | 16.64 Million | 19.83 Million | 851.79 Thousand | 14.24 Million | 3.74 Million | 14.74 Million |
Other Investing Activities | 183.4 Million | 47.94 Million | 113.77 Million | -23.51 Million | 222.63 Million | 4.01 Million |
Financing Cash Flow | -358.67 Million | 64.42 Million | -356.61 Million | -340.75 Million | -119.69 Million | -41.63 Million |
Debt repayment | -65.73 Million | -1.09 Billion | -410.24 Million | -156.15 Million | -1.17 Billion | -1.05 Billion |
Dividends payments | -64.34 Million | -60 Million | -2.8 Million | -2.12 Million | - | - |
Common Stock Repurchased | -3.96 Million | - | -6.65 Million | - | -4.74 Million | - |
Common Stock Issuance | - | - | 359.11 Million | 123.17 Million | 4.02 Million | 4.36 Million |
Other Financing Activities | -224.62 Million | 1.22 Billion | -296.02 Million | -184.59 Million | 1.98 Billion | 1 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 599.99 Million | 480.98 Million | 297.49 Million | 456.21 Million | 418.05 Million | 489.04 Million |
Cash at end of period | 353.94 Million | 599.99 Million | 480.98 Million | 296.47 Million | 456.21 Million | 418.05 Million |
Capital Expenditure | -300.29 Million | -268.54 Million | -111.14 Million | -191.11 Million | -196.66 Million | -245.53 Million |
Effect of forex changes on cash | -3.19 Million | 4.08 Million | -807.93 Thousand | -489.05 Thousand | 2.2 Million | -2.74 Million |
Net cash flow / Change in cash | -246.04 Million | 119.01 Million | 183.49 Million | -159.73 Million | 38.16 Million | -70.98 Million |
Free Cash Flow | 452.75 Million | 844.92 Million | 189.36 Million | 9.3 Million | -27.17 Million | -5.42 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 75.44 Million | 129.34 Million | 72.92 Million | 141.83 Million | 373.09 Million | 118.39 Million |
Depreciation & Amortization | 147.46 Million | 147.12 Million | 147.39 Million | 95.02 Million | 462.9 Million | 86.31 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 1.21 Million | 839.11 Thousand | -470.92 Thousand | 393.09 Thousand | 470.92 Thousand |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 30.65 Million | 344.28 Million | 245.95 Million | 41.68 Million | 598.37 Million | 166.86 Million |
Investing Cash Flow | -163.01 Million | -6.55 Million | -101.23 Million | -600.56 Million | -663.64 Million | -60.03 Million |
Investments in PPE | -92.95 Million | -78.6 Million | -100.21 Million | -123.36 Million | -302.08 Million | -78.36 Million |
Acquisitions | 20.03 Thousand | 116.57 Million | - | -520.33 Million | -491.72 Million | 165.33 Thousand |
Investment purchases | 21 Million | -37 Million | -2.5 Million | -2.15 Million | -35.02 Million | -23.83 Million |
Sales/Maturities of investments | -21 Million | 21 Million | - | 6.13 Million | 16.64 Million | 4.41 Million |
Other Investing Activities | -25.46 Million | -28.52 Million | -1.01 Million | 39.14 Million | 148.56 Million | 37.58 Million |
Financing Cash Flow | -71.89 Million | -134.64 Million | -22.48 Million | 339.34 Million | -87.77 Million | -248.15 Million |
Debt repayment | -29.7 Million | -47.37 Million | -27.35 Million | -350.73 Million | -74.15 Million | -231.7 Million |
Dividends payments | - | -44.86 Million | - | -24.34 Million | -64.34 Million | - |
Common Stock Repurchased | - | - | -3 Million | - | -3.96 Million | -2.09 Million |
Common Stock Issuance | - | - | - | - | - | 238.41 Thousand |
Other Financing Activities | -42.19 Million | -2.68 Million | -7.25 Million | 60.35 Million | 46.26 Million | -14.34 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 652.5 Million | 478.02 Million | 424.73 Million | 665.59 Million | 737.21 Million | 466.13 Million |
Cash at end of period | 671.57 Million | 652.5 Million | 478.02 Million | 424.73 Million | 424.73 Million | 527.24 Million |
Capital Expenditure | -92.95 Million | -78.6 Million | -100.21 Million | -123.36 Million | -302.08 Million | -78.36 Million |
Effect of forex changes on cash | - | -3.35 Million | 236.92 Thousand | -570.54 Thousand | -3.19 Million | -2.73 Million |
Net cash flow / Change in cash | 19.06 Million | 174.48 Million | 53.28 Million | -240.85 Million | -312.47 Million | 61.1 Million |
Free Cash Flow | 160.6 Million | 247.9 Million | 71.26 Million | -34.87 Million | 206.47 Million | 293.67 Million |
603408
ICPVF
300512
GRIN
CLVR
603036